BioCentury | Oct 27, 2020
Product Development

Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen

...ASN) 2020 Annual Meeting.CE mark for Kantaro’s quantitative COVID-19 serology testsKantaro Biosciences LLC and partner Bio-Techne...
BioCentury | Aug 22, 2020
Emerging Company Profile

Luminary: turning cell engineering tools into therapies

...acquisition by research tools and services company Bio-Techne...
...therapies.According to Luminary co-founder and CEO Jeff Liter, Bio-Techne...
...the coming months Luminary will license from Bio-Techne...
BioCentury | Jan 25, 2020
Tools & Techniques

Manufacturing roundup: Deerfield launches new CDMO, plus a gene/cell therapy JV and more

...critically needed cell and gene therapies,” the partners said in a statement. Separately, on Tuesday, Bio-Techne...
...technologies and processes into one manufacturing platform to develop and commercialize cell and gene therapies. Bio-Techne...
...CD279) - Programmed cell death 1 TGF-β - Transforming growth factor beta Elizabeth S. Eaton, Staff Writer Bio-Techne...
BioCentury | Jan 22, 2020
Company News

JV to combine technologies into one gene and cell therapy manufacturing platform

...in the development of next-generation gene and cell therapies. The first, a joint venture between Bio-Techne...
...technologies and processes into one manufacturing platform to develop and commercialize cell and gene therapies. Bio-Techne...
...S. Eaton, Staff Writer Bellicum Pharmaceuticals Inc. University of Texas MD Anderson Cancer Center Fresenius SE & Co. KGaA Bio-Techne...
BioCentury | Apr 25, 2019
Emerging Company Profile

miR Scientific: spotting aggression with RNA in urine

...cancer tests based on detection of five mRNAs; and the Exosome Diagnostics Inc. unit of Bio-Techne...
...Patents: None issued Companies and Institutions Mentioned American Society of Clinical Oncology (ASCO), Alexandria, Va. Bio-Techne...
BioCentury | Feb 28, 2019
Distillery Therapeutics

Inflammation

...inflammatory cytokine levels in the plasma, liver, lung, spleen and bone marrow. Ongoing work by Bio-Techne...
...TARGET/MARKER/PATHWAY: Interleukin-37 (IL-37; IL-1F7) LICENSING STATUS: Patent application filed by University of Colorado Denver and Bio-Techne...
...18, 2019 doi:10.1073/pnas.1821111116 CONTACT: Charles A. Dinarello, University of Colorado Denver, Aurora, Colo. email: cdinare333@aol.com Claire Quang Bio-Techne...
BioCentury | Jun 29, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for...
...predict whether men have high-risk prostate cancer prior to biopsy. Exosome Diagnostics Inc., Waltham, Mass. Bio-Techne...
...Corp. (NASDAQ:TECH), Minneapolis, Minn. Business: Diagnostic, Cancer Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne...
BioCentury | Jun 26, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for...
...exosomes and is used to predict whether men have high-risk prostate cancer prior to biopsy. Bio-Techne...
...was off $1.22 to $157.03 on Tuesday. Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne...
BioCentury | Apr 25, 2018
Company News

Management tracks: Urovant, Cue

...Sam Raha, SVP of strategy and coporate development, will become president of DGG. Research supplier Bio-Techne...
BioCentury | Nov 2, 2017
Company News

Bio-Techne acquires Trevigen

...In September, Bio-Techne Corp. (NASDAQ:TECH) acquired fellow supply and service company Trevigen Inc. (Gaithersburg, Md.) for...
...damage and repair. Trevigen Inc., Gaithersburg, Md. Bio-Techne Corp. (NASDAQ:TECH), Minneapolis, Minn. Business: Supply/Service Elizabeth S. Eaton Bio-Techne...
Items per page:
1 - 10 of 36
BioCentury | Oct 27, 2020
Product Development

Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen

...ASN) 2020 Annual Meeting.CE mark for Kantaro’s quantitative COVID-19 serology testsKantaro Biosciences LLC and partner Bio-Techne...
BioCentury | Aug 22, 2020
Emerging Company Profile

Luminary: turning cell engineering tools into therapies

...acquisition by research tools and services company Bio-Techne...
...therapies.According to Luminary co-founder and CEO Jeff Liter, Bio-Techne...
...the coming months Luminary will license from Bio-Techne...
BioCentury | Jan 25, 2020
Tools & Techniques

Manufacturing roundup: Deerfield launches new CDMO, plus a gene/cell therapy JV and more

...critically needed cell and gene therapies,” the partners said in a statement. Separately, on Tuesday, Bio-Techne...
...technologies and processes into one manufacturing platform to develop and commercialize cell and gene therapies. Bio-Techne...
...CD279) - Programmed cell death 1 TGF-β - Transforming growth factor beta Elizabeth S. Eaton, Staff Writer Bio-Techne...
BioCentury | Jan 22, 2020
Company News

JV to combine technologies into one gene and cell therapy manufacturing platform

...in the development of next-generation gene and cell therapies. The first, a joint venture between Bio-Techne...
...technologies and processes into one manufacturing platform to develop and commercialize cell and gene therapies. Bio-Techne...
...S. Eaton, Staff Writer Bellicum Pharmaceuticals Inc. University of Texas MD Anderson Cancer Center Fresenius SE & Co. KGaA Bio-Techne...
BioCentury | Apr 25, 2019
Emerging Company Profile

miR Scientific: spotting aggression with RNA in urine

...cancer tests based on detection of five mRNAs; and the Exosome Diagnostics Inc. unit of Bio-Techne...
...Patents: None issued Companies and Institutions Mentioned American Society of Clinical Oncology (ASCO), Alexandria, Va. Bio-Techne...
BioCentury | Feb 28, 2019
Distillery Therapeutics

Inflammation

...inflammatory cytokine levels in the plasma, liver, lung, spleen and bone marrow. Ongoing work by Bio-Techne...
...TARGET/MARKER/PATHWAY: Interleukin-37 (IL-37; IL-1F7) LICENSING STATUS: Patent application filed by University of Colorado Denver and Bio-Techne...
...18, 2019 doi:10.1073/pnas.1821111116 CONTACT: Charles A. Dinarello, University of Colorado Denver, Aurora, Colo. email: cdinare333@aol.com Claire Quang Bio-Techne...
BioCentury | Jun 29, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for...
...predict whether men have high-risk prostate cancer prior to biopsy. Exosome Diagnostics Inc., Waltham, Mass. Bio-Techne...
...Corp. (NASDAQ:TECH), Minneapolis, Minn. Business: Diagnostic, Cancer Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne...
BioCentury | Jun 26, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for...
...exosomes and is used to predict whether men have high-risk prostate cancer prior to biopsy. Bio-Techne...
...was off $1.22 to $157.03 on Tuesday. Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne...
BioCentury | Apr 25, 2018
Company News

Management tracks: Urovant, Cue

...Sam Raha, SVP of strategy and coporate development, will become president of DGG. Research supplier Bio-Techne...
BioCentury | Nov 2, 2017
Company News

Bio-Techne acquires Trevigen

...In September, Bio-Techne Corp. (NASDAQ:TECH) acquired fellow supply and service company Trevigen Inc. (Gaithersburg, Md.) for...
...damage and repair. Trevigen Inc., Gaithersburg, Md. Bio-Techne Corp. (NASDAQ:TECH), Minneapolis, Minn. Business: Supply/Service Elizabeth S. Eaton Bio-Techne...
Items per page:
1 - 10 of 36